Manning & Napier Group's ELV Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 24.2K shares of Elevance Health, Inc. (ELV) worth $7.82 M, representing 0.10% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Manning & Napier Group has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 20.5K shares. Largest reduction occurred in Q3 2025, reducing 14.0K shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Manning & Napier Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2019 | +926 | New Buy | 926 | $301.30 |
| Q1 2020 | -15 | Reduce 1.62% | 911 | $226.13 |
| Q2 2020 | -911 | Sold Out | 911 | $0.00 |
| Q4 2024 | +9,146 | New Buy | 9,146 | $368.90 |
| Q1 2025 | +8,613 | Add 94.17% | 17,759 | $434.96 |
| Q2 2025 | +20,455 | Add 115.18% | 38,214 | $388.96 |
| Q3 2025 | -14,025 | Reduce 36.70% | 24,189 | $323.12 |
Manning & Napier Group's Elevance Health Investment FAQs
Manning & Napier Group first purchased Elevance Health, Inc. (ELV) in Q4 2019, acquiring 926 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Elevance Health, Inc. (ELV) for 24 quarters since Q4 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's largest addition to Elevance Health, Inc. (ELV) was in Q2 2025, adding 38,214 shares worth $14.86 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 24,189 shares of Elevance Health, Inc. (ELV), valued at approximately $7.82 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Elevance Health, Inc. (ELV) represents approximately 0.10% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's peak holding in Elevance Health, Inc. (ELV) was 38,214 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.